| Tender Details | ||||||||
|
||||||||
| Deadline * | ||||||||
|
||||||||
| Client Address | ||||||||
|
||||||||
| More Information | ||||||||
| Know More | ||||||||
Similar Tenders
- Ref No: 4269916
- Location: Germany
Contract Announcement Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Drugs With The Active I
- Deadline: 10 Aug 2026
- Ref No: 5400942
- Location: Bulgaria
Chipboard Supply Of Disinfectants For Umbal St Ivan Rilski Ead
- Deadline: 03 May 2027
- Ref No: 5442767
- Location: Bulgaria
Chipboard Supply Of Disinfectants For Umbal St Ivan Rilski Ead
- Deadline: 03 May 2027
- Ref No: 5977915
- Location: Germany
Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred
- Deadline: 31 Jul 2026
- Ref No: 5978377
- Location: Germany
Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred
- Deadline: 30 Jun 2026
- Ref No: 6171828
- Location: Germany
Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Tr
- Deadline: 31 Jul 2026
- Ref No: 6173952
- Location: Germany
Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Tr
- Deadline: 31 Jul 2026
- Ref No: 6175344
- Location: Germany
Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Tr
- Deadline: 31 Jul 2026
- Ref No: 6189911
- Location: Germany
Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient F
- Deadline: 27 May 2026
- Ref No: 6223493
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Acti
- Deadline: 31 May 2026